Suppr超能文献

相似文献

1
3
Synphilin isoforms and the search for a cellular model of lewy body formation in Parkinson's disease.
Cell Cycle. 2006 Sep;5(18):2082-6. doi: 10.4161/cc.5.18.3209. Epub 2006 Sep 15.
5
TRIM9-Mediated Resolution of Neuroinflammation Confers Neuroprotection upon Ischemic Stroke in Mice.
Cell Rep. 2019 Apr 9;27(2):549-560.e6. doi: 10.1016/j.celrep.2018.12.055.
6
Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.
Am J Pathol. 2002 May;160(5):1655-67. doi: 10.1016/S0002-9440(10)61113-3.
7
Pathological roles of α-synuclein in neurological disorders.
Lancet Neurol. 2011 Nov;10(11):1015-25. doi: 10.1016/S1474-4422(11)70213-7.
8
TIGAR inclusion pathology is specific for Lewy body diseases.
Brain Res. 2019 Mar 1;1706:218-223. doi: 10.1016/j.brainres.2018.09.032. Epub 2018 Sep 26.
9
Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease.
Neurogenetics. 2008 Jul;9(3):163-72. doi: 10.1007/s10048-008-0124-6. Epub 2008 Mar 12.
10
Ubiquitination of alpha-synuclein and autophagy in Parkinson's disease.
Autophagy. 2008 Apr;4(3):372-4. doi: 10.4161/auto.5604. Epub 2008 Jan 18.

引用本文的文献

2
Advancing brain tumor therapy: unveiling the potential of PROTACs for targeted protein degradation.
Cytotechnology. 2025 Apr;77(2):54. doi: 10.1007/s10616-025-00716-8. Epub 2025 Jan 31.
4
E3 ubiquitin ligase TRIM31 alleviates dopaminergic neurodegeneration by promoting proteasomal degradation of VDAC1 in Parkinson's Disease model.
Cell Death Differ. 2024 Nov;31(11):1410-1421. doi: 10.1038/s41418-024-01334-1. Epub 2024 Jun 25.
5
Targeted protein degradation in CNS disorders: a promising route to novel therapeutics?
Front Mol Neurosci. 2024 Apr 15;17:1370509. doi: 10.3389/fnmol.2024.1370509. eCollection 2024.
6
Trim9 regulates the directional differentiation of retinal Müller cells to retinal ganglion cells.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Oct 28;48(10):1561-1571. doi: 10.11817/j.issn.1672-7347.2023.230108.
7
Multi-monoubiquitylation controls VASP-mediated actin dynamics.
J Cell Sci. 2024 Jan 15;137(2). doi: 10.1242/jcs.261527. Epub 2024 Jan 26.
8
It's a TRIM-endous view from the top: the varied roles of TRIpartite Motif proteins in brain development and disease.
Front Mol Neurosci. 2023 Dec 5;16:1287257. doi: 10.3389/fnmol.2023.1287257. eCollection 2023.
9
Detection of High-Risk Paraneoplastic Antibodies against TRIM9 and TRIM67 Proteins.
Ann Neurol. 2023 Dec;94(6):1086-1101. doi: 10.1002/ana.26776. Epub 2023 Sep 19.
10
Evolution and expression of the duck TRIM gene repertoire.
Front Immunol. 2023 Aug 9;14:1220081. doi: 10.3389/fimmu.2023.1220081. eCollection 2023.

本文引用的文献

1
TRIM36 interacts with the kinetochore protein CENP-H and delays cell cycle progression.
Biochem Biophys Res Commun. 2009 Apr 10;381(3):383-7. doi: 10.1016/j.bbrc.2009.02.059. Epub 2009 Feb 20.
3
Ubiquitin signals autophagic degradation of cytosolic proteins and peroxisomes.
Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20567-74. doi: 10.1073/pnas.0810611105. Epub 2008 Dec 12.
4
Ubiquitination of E3 ubiquitin ligase TRIM5 alpha and its potential role.
FEBS J. 2008 Apr;275(7):1540-1555. doi: 10.1111/j.1742-4658.2008.06313.x. Epub 2008 Feb 25.
5
Epitope mapping of 2E2-D3, a monoclonal antibody directed against human TDP-43.
Neurosci Lett. 2008 Mar 28;434(2):170-4. doi: 10.1016/j.neulet.2008.01.060. Epub 2008 Feb 2.
7
Amplitude control of protein kinase C by RINCK, a novel E3 ubiquitin ligase.
J Biol Chem. 2007 Nov 16;282(46):33776-33787. doi: 10.1074/jbc.M703320200. Epub 2007 Sep 24.
10
TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity.
Nature. 2007 Apr 19;446(7138):916-920. doi: 10.1038/nature05732.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验